These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26768568)

  • 1. Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challenges.
    Vandebosch A; Mogg R; Goeyvaerts N; Truyers C; Greenwood B; Watson-Jones D; Herrera-Taracena G; Parys W; Vangeneugden T
    Clin Trials; 2016 Feb; 13(1):57-65. PubMed ID: 26768568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistics and logistics: Design of Ebola vaccine trials in West Africa.
    Nason M
    Clin Trials; 2016 Feb; 13(1):87-91. PubMed ID: 26768560
    [No Abstract]   [Full Text] [Related]  

  • 3. Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges.
    Kennedy SB; Neaton JD; Lane HC; Kieh MW; Massaquoi MB; Touchette NA; Nason MC; Follmann DA; Boley FK; Johnson MP; Larson G; Kateh FN; Nyenswah TG
    Clin Trials; 2016 Feb; 13(1):49-56. PubMed ID: 26768572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak.
    Higgs ES; Dubey SA; Coller BAG; Simon JK; Bollinger L; Sorenson RA; Wilson B; Nason MC; Hensley LE
    Curr Top Microbiol Immunol; 2017; 411():229-261. PubMed ID: 28918539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing an Ebola Vaccine Study - Sierra Leone.
    Widdowson MA; Schrag SJ; Carter RJ; Carr W; Legardy-Williams J; Gibson L; Lisk DR; Jalloh MI; Bash-Taqi DA; Kargbo SA; Idriss A; Deen GF; Russell JB; McDonald W; Albert AP; Basket M; Callis A; Carter VM; Ogunsanya KR; Gee J; Pinner R; Mahon BE; Goldstein ST; Seward JF; Samai M; Schuchat A
    MMWR Suppl; 2016 Jul; 65(3):98-106. PubMed ID: 27387395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone.
    Camacho A; Eggo RM; Goeyvaerts N; Vandebosch A; Mogg R; Funk S; Kucharski AJ; Watson CH; Vangeneugden T; Edmunds WJ
    Vaccine; 2017 Jan; 35(4):544-551. PubMed ID: 28024952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ebola vaccine, therapeutics, and diagnostics].
    Furuyama W; Takada A
    Uirusu; 2016; 66(1):63-72. PubMed ID: 28484180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A vaccine against Ebola: Problems and opportunities.
    Rezza G
    Hum Vaccin Immunother; 2015; 11(5):1258-60. PubMed ID: 25901415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overview of the Ebola vaccines in pre-clinical and clinical development].
    Buchy P
    Bull Soc Pathol Exot; 2016 Oct; 109(4):256-261. PubMed ID: 27646961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis.
    Bellan SE; Pulliam JR; Pearson CA; Champredon D; Fox SJ; Skrip L; Galvani AP; Gambhir M; Lopman BA; Porco TC; Meyers LA; Dushoff J
    Lancet Infect Dis; 2015 Jun; 15(6):703-10. PubMed ID: 25886798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine.
    Zhou Y; Sullivan NJ
    Curr Opin Immunol; 2015 Aug; 35():131-6. PubMed ID: 26247875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritising Healthcare Workers for Ebola Treatment: Treating Those at Greatest Risk to Confer Greatest Benefit.
    Satalkar P; Elger BE; Shaw DM
    Dev World Bioeth; 2015 Aug; 15(2):59-67. PubMed ID: 25655050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials of Ebola vaccine must continue despite fall in number of cases.
    Gulland A
    BMJ; 2015 Feb; 350():h944. PubMed ID: 25691506
    [No Abstract]   [Full Text] [Related]  

  • 14. Unprecedented pace and partnerships: the story of and lessons learned from one Ebola vaccine program.
    Gupta SB; Coller BA; Feinberg M
    Expert Rev Vaccines; 2018 Oct; 17(10):913-923. PubMed ID: 30269612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola virus vaccine: benefit and risks of adenovirus-based vectors.
    Mennechet FJ; Tran TT; Eichholz K; van de Perre P; Kremer EJ
    Expert Rev Vaccines; 2015; 14(11):1471-8. PubMed ID: 26325242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context.
    Lhomme E; Modet C; Augier A; Faye S; Dabakuyo-Yonli TS; Levy-Marchal C; D'Ortenzio E; Yazdanpanah Y; Chêne G; Beavogui AH; Richert L;
    Trials; 2019 Jul; 20(1):422. PubMed ID: 31296253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
    Henao-Restrepo AM; Longini IM; Egger M; Dean NE; Edmunds WJ; Camacho A; Carroll MW; Doumbia M; Draguez B; Duraffour S; Enwere G; Grais R; Gunther S; Hossmann S; Kondé MK; Kone S; Kuisma E; Levine MM; Mandal S; Norheim G; Riveros X; Soumah A; Trelle S; Vicari AS; Watson CH; Kéïta S; Kieny MP; Røttingen JA
    Lancet; 2015 Aug; 386(9996):857-66. PubMed ID: 26248676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Ordered Stepped-Wedge Cluster Trial Designs for Detecting Ebola Vaccine Efficacy Using a Spatially Structured Mathematical Model.
    Diakite I; Mooring EQ; Velásquez GE; Murray MB
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004866. PubMed ID: 27509037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering assumptions about stepped wedge designs: the case of Ebola vaccine research.
    Doussau A; Grady C
    J Med Ethics; 2016 Dec; 42(12):797-804. PubMed ID: 27754861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebola vaccines - Where are we?
    Watle SV; Norheim G; Røttingen JA
    Hum Vaccin Immunother; 2016 Oct; 12(10):2700-2703. PubMed ID: 27548643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.